ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 8 analysts with an average price target of $88.75. This is a potential upside of $19.63 (28.4%) from yesterday's end of day stock price of $69.12.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 258 price targets and 201 ratings on display. The stock rating distribution of ARWR is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.88% with an average time for these price targets to be met of 379.74 days.

Highest price target for ARWR is $110, Lowest price target is $17, average price target is $65.

Most recent stock forecast was given by EDWARD TENTHOFF from PIPER SANDLER on 13-Jan-2026. First documented stock forecast 05-Mar-2014.

Currently out of the existing stock ratings of ARWR, 16 are a BUY (80%), 4 are a HOLD (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Nov-2017

$110

$42.95 (64.06%)

$100

16 days ago
(13-Jan-2026)

29/39 (74.36%)

$44.45 (67.81%)

286

Buy Since 16-Sep-2020

$80

$12.95 (19.31%)

$60

22 days ago
(07-Jan-2026)

20/24 (83.33%)

$14.31 (21.78%)

453

Hold Since 30-Nov-2023

$81

$13.95 (20.81%)

$48

22 days ago
(07-Jan-2026)

3/5 (60%)

$15.31 (23.31%)

32

Buy Since 04-Dec-2023

$62

$-5.05 (-7.53%)

$41

1 months 28 days ago
(01-Dec-2025)

5/5 (100%)

$9.3 (17.65%)

194

Buy Since 12-May-2020

$52

$-15.05 (-22.45%)

$40

2 months 10 days ago
(19-Nov-2025)

10/12 (83.33%)

$11.53 (28.49%)

395

Show more analysts

Please expand the browser size to see the chart

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 379.74 days on average for the stock forecasts to be realized with a an average price target met ratio 80.88

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Patrick Trucchio has 5 price targets and 9 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Edward Tenthoff with highest potential upside - $42.95

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Shawn Egan with lowest potential downside - -$50.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?